Higher prevalence and distinct features of herpes zoster infection in children than adults with systemic lupus erythematosus

Pediatric Infectious Disease Journal

Volumn 34, Issue 8, 2015, Pages 905-907

  Gormezano, Natali W S ^a   Silva, Clovis A ^a   Otsuzi, Carini I ^a   Barros, Diego L ^a   Da Silva, Mariana A ^a   Sallum, Adriana M E ^a   Pasoto, Sandra ^a   Pereira, Rosa M R ^a   Bonfá, Eloisa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

adult systemic lupus erythematosus; childhood systemic lupus erythematosus; herpes zoster; postherpetic neuralgia

Indexed keywords

ACICLOVIR; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; MYCOPHENOLATE MOFETIL; PREDNISONE;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CHILD; CLINICAL FEATURE; DEMOGRAPHY; DISEASE ACTIVITY SCORE; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HEMATURIA; HERPES ZOSTER; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTURIA; MAJOR CLINICAL STUDY; NEPHRITIS; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TERTIARY CARE CENTER; COMPLICATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREVALENCE; VIROLOGY;

ADULT; CHILD; HERPES ZOSTER; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84937407273     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000756     Document Type: Article

References (12)

1. Lee PP, Lee TL, Ho MH, et al. Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors. Pediatr Infect Dis J. 2006; 25: 728-732
2. Chakravarty EF, Michaud K, Katz R, et al. Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Lupus. 2013; 22: 238-244
3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40: 1725
4. Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014; 4: e004833
5. Kost RG, Straus SE. Postherpetic neuralgia-pathogenesis, treatment, and prevention. N Engl J Med. 1996; 335: 32-42
6. Gladman DD, Goldsmith CH, Urowitz MB, et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index for systemic lupus erythematosus international comparison. J Rheumatol. 2000; 27: 373-376
7. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002; 29: 288-291
8. Barbosa CM, Terreri MT, Rosário PO, et al. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus. Clin Exp Rheumatol. 2012; 30: 791-798
9. Park HB, Kim KC, Park JH, et al. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus. J Rheumatol. 2004; 31: 2151-2155
10. Borba EF, Ribeiro AC, Martin P, et al. Incidence, risk factors, and outcome of herpes zoster in systemic lupus erythematosus. J Clin Rheumatol. 2010; 16: 119-122
11. Faco MM, Leone C, Campos LM, et al. Factors associated to death in patients hospitalized with juvenile systemic lupus erythematosus. Braz J Med Biol Res. 2007; 40: 993-1002
12. Guthridge JM, Cogman A, Merrill JT, et al. Herpes zoster vaccination in SLE: a pilot study of immunogenicity. J Rheumatol. 2013; 40: 1875-1880